Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1967 (LINC01967) is a member of the long intergenic non-coding RNA family, characterized as an autonomously transcribed, non-protein-coding RNA locus longer than 200 nucleotides that does not overlap with annotated protein-coding genes[1][5]. LincRNAs play roles in chromatin remodeling, genome architecture, transcription regulation, RNA stabilization, and the modulation of gene expression—often with tissue-specific expression and diverse cellular functions. While some lincRNAs are implicated in development and disease, there are currently no specific biological, disease-related, or therapeutic functional data available for LINC01967 itself. As such, it is classified molecularly as a lincRNA, but is not a recognized therapeutic target or biomarker at this time[1][5]. If further characterization or disease association for LINC01967 emerges, annotations should be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1967 (LINC01967).